Skip to main content
. Author manuscript; available in PMC: 2017 Nov 28.
Published in final edited form as: Nat Genet. 2014 Jun 29;46(8):844–849. doi: 10.1038/ng.3016

Figure 2.

Figure 2

GTF2I mutation in TETs. (a) Frequency of GTF2I mutation by WHO histotype (combining the results of all analytic platforms). The number of patients sequenced is given in parenthesis next to each WHO histotype. (b) Kaplan-Meier survival curve demonstrating a more favorable outcome in GTF2I-mutated (MUT, blue line) than in wild-type (WT, red line) TETs (log-rank test P < 0.001; 83 and 121 evaluable patients, respectively).